 <h1>Nintedanib Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of nintedanib include:</b> abdominal pain, abdominal tenderness, abnormal hepatic function tests, diarrhea, gastrointestinal pain, increased gamma-glutamyl transferase, increased liver enzymes, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, increased serum transaminases, lower abdominal pain, nausea, upper abdominal pain, vomiting, weight loss, hemorrhage, and decreased appetite.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to nintedanib: oral capsule</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, nintedanib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking nintedanib:</p><p>
<i>More common</i>
</p><ul>
<li>Diarrhea</li>
<li>nausea</li>
<li>severe stomach pain</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach pain or swelling</li>
<li>black, tarry stools</li>
<li>blood in the urine</li>
<li>blurred vision</li>
<li>bruising or purple areas on the skin</li>
<li>chest pain or discomfort</li>
<li>coughing up blood</li>
<li>decreased alertness</li>
<li>dizziness</li>
<li>headache</li>
<li>irregular heartbeat</li>
<li>joint pain or swelling</li>
<li>nervousness</li>
<li>nosebleeds</li>
<li>pain in the chest, groin, or legs, especially calves of the legs</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>pounding in the ears</li>
<li>severe headaches of sudden onset</li>
<li>shortness of breath</li>
<li>slow or fast heartbeat</li>
<li>sudden loss of coordination</li>
<li>sudden onset of shortness of breath for no apparent reason</li>
<li>sudden onset of slurred speech</li>
<li>sudden vision changes</li>
<li>sweating</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of nintedanib may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Decreased appetite</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Constipation</li>
<li>depression</li>
<li>dry skin and hair</li>
<li>feeling cold</li>
<li>hair loss</li>
<li>hoarseness or husky voice</li>
<li>muscle cramps and stiffness</li>
<li>slow heartbeat</li>
<li>unusual tiredness or weakness</li>
<li>weight gain</li>
</ul><p>
<!-- end oral capsule --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nintedanib: oral capsule</i></p><h3>General</h3><p>The most common side effects included diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, weight decreased, hypertension, and peripheral neuropathy.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (62%), nausea (24%), abdominal pain (15%), vomiting (12%), constipation (12%), abdominal pain, mucositis (including stomatitis)</p>
<p><b>Uncommon</b> (0.1% to 1%): Pancreatitis, GI perforation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, venous thromboembolism, myocardial infarction, chest pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypertension<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Neutropenia (14%), hemoglobinemia (12%), bleeding events (10%)</p>
<p><b>Common</b> (1% to 10%): Febrile neutropenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Liver enzyme elevation (14%)</p>
<p><b>Common</b> (1% to 10%): Hyperbilirubinemia, alanine aminotransferase (ALT) increased, aspartate aminotransferase (AST) increased, gamma glutamyl transferase (GGT) increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Drug induced liver injury, hyperbilirubinemia, blood alkaline phosphatase (ALKP) increased<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (18%), rash<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Hypothyroidism<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (11%), weight loss (10%)</p>
<p><b>Common</b> (1% to 10%): Dehydration</p>
<p><b>Frequency not reported</b>: Electrolyte imbalance<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Peripheral neuropathy (19%)</p>
<p><b>Common</b> (1% to 10%): Headache<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Lung neoplasm malignant<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (27%), pyrexia (15%)</p>
<p><b>Frequency not reported</b>: Embryofetal toxicity<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Nasopharyngitis (56%), bronchitis (11%), dyspnea (17%), cough (17%), idiopathic pulmonary fibrosis (10%)</p>
<p><b>Common</b> (1% to 10%): Upper respiratory tract infection, pneumonia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Abscesses, sepsis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, arthralgia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Ofev (nintedanib)." Boehringer Ingelheim, Ridgefield, CT. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about nintedanib</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>2 Reviews</li>
<li>Drug class: multikinase inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nintedanib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Ofev</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Idiopathic Pulmonary Fibrosis</li>
<li>Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype</li>
<li>Systemic Sclerosis-Associated Interstitial Lung Disease</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to nintedanib: oral capsule</i></p><h3>General</h3><p>The most common side effects included diarrhea, nausea, abdominal pain, vomiting, liver enzyme elevation, decreased appetite, headache, weight decreased, hypertension, and peripheral neuropathy.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (62%), nausea (24%), abdominal pain (15%), vomiting (12%), constipation (12%), abdominal pain, mucositis (including stomatitis)</p><p><b>Uncommon</b> (0.1% to 1%): Pancreatitis, GI perforation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, venous thromboembolism, myocardial infarction, chest pain</p><p><b>Uncommon</b> (0.1% to 1%): Hypertension<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Neutropenia (14%), hemoglobinemia (12%), bleeding events (10%)</p><p><b>Common</b> (1% to 10%): Febrile neutropenia</p><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Liver enzyme elevation (14%)</p><p><b>Common</b> (1% to 10%): Hyperbilirubinemia, alanine aminotransferase (ALT) increased, aspartate aminotransferase (AST) increased, gamma glutamyl transferase (GGT) increased</p><p><b>Uncommon</b> (0.1% to 1%): Drug induced liver injury, hyperbilirubinemia, blood alkaline phosphatase (ALKP) increased<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (18%), rash<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Hypothyroidism<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (11%), weight loss (10%)</p><p><b>Common</b> (1% to 10%): Dehydration</p><p><b>Frequency not reported</b>: Electrolyte imbalance<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Peripheral neuropathy (19%)</p><p><b>Common</b> (1% to 10%): Headache<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Lung neoplasm malignant<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (27%), pyrexia (15%)</p><p><b>Frequency not reported</b>: Embryofetal toxicity<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Nasopharyngitis (56%), bronchitis (11%), dyspnea (17%), cough (17%), idiopathic pulmonary fibrosis (10%)</p><p><b>Common</b> (1% to 10%): Upper respiratory tract infection, pneumonia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Abscesses, sepsis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, arthralgia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Ofev (nintedanib)." Boehringer Ingelheim, Ridgefield, CT. </p><h2>More about nintedanib</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>2 Reviews</li>
<li>Drug class: multikinase inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nintedanib &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Idiopathic Pulmonary Fibrosis</li>
<li>Chronic Fibrosing Interstitial Lung Disease With A Progressive Phenotype</li>
<li>Systemic Sclerosis-Associated Interstitial Lung Disease</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>